Pre-Made Albinterferon Alfa- 2B Biosimilar, Fusion Protein targeting IFNAR1 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Chronic hepatitis C (CHC) is one of the most common causes of chronic liver disease. Albinterferon alfa-2b (alb-IFN) is an 85.7-kilodalton protein consisting of recombinant human interferon (IFN) alfa-2b genetically fused to recombinant human albumin. alb-IFN retains the antiviral properties of IFN alfa, with significant suppression of HCV RNA in the replicon system.